Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.
2.

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.

Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh HJ 3rd.

Cancer. 2010 Aug 15;116(16):3756-62. doi: 10.1002/cncr.25116.

3.

[Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].

Mátrai Z, Péley G, Kovács T, Rényi VF, Szívós E, Szabó E, Vereczkey I, Török K, Köves I.

Orv Hetil. 2006 Jan 29;147(4):147-58. Review. Hungarian.

PMID:
16515023
4.

Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.

Detroz B, Laurent S, Honoré P, Blaffart F, Limet R, Meurisse M.

Acta Chir Belg. 2004 Aug;104(4):377-83. Review.

PMID:
15469146
5.

Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.

Iversen LH, Rasmussen PC, Laurberg S.

Br J Surg. 2013 Jan;100(2):285-92. doi: 10.1002/bjs.8908. Epub 2012 Nov 2.

PMID:
23124619
6.

Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.

Deraco M, Gronchi A, Mazzaferro V, Inglese MG, Pennacchioli E, Kusamura S, Rizzi M, Anselmi RA Jr, Vaglini M.

Tumori. 2002 Sep-Oct;88(5):370-5.

PMID:
12487553
7.

Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome.

Macrì A, Maugeri I, Trimarchi G, Caminiti R, Saffioti MC, Incardona S, Sinardi A, Irato S, Altavilla G, Adamo V, Versaci A, Famulari C.

In Vivo. 2009 Jan-Feb;23(1):147-50.

8.

Quality of life after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy for peritoneal carcinomatosis: A systematic review and meta-analysis.

Shan LL, Saxena A, Shan BL, Morris DL.

Surg Oncol. 2014 Dec;23(4):199-210. doi: 10.1016/j.suronc.2014.10.002. Epub 2014 Oct 28. Review.

PMID:
25466850
9.

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.

Nesher E, Greenberg R, Avital S, Skornick Y, Schneebaum S.

Isr Med Assoc J. 2007 Nov;9(11):787-90.

10.

[Hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis arising from gastric cancer].

Cotte E, Gilly FN, Beaujard AC, Glehen O.

Cancer Radiother. 2008 Nov;12(6-7):653-8. doi: 10.1016/j.canrad.2008.05.002. Epub 2008 Jul 17. French.

PMID:
18639480
11.

Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.

Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR.

Am Surg. 2000 Jun;66(6):561-8.

PMID:
10888132
12.

Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy.

Kim KW, Chow O, Parikh K, Blank S, Jibara G, Kadri H, Labow DM, Hiotis SP.

Am J Surg. 2014 Jan;207(1):78-83. doi: 10.1016/j.amjsurg.2013.04.010. Epub 2013 Oct 21.

PMID:
24157224
13.
14.

Life after hyperthermic intraperitoneal chemotherapy; measuring quality of life and performance status after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

Ford J, Hanna M, Boston A, Berri R.

Am J Surg. 2016 Mar;211(3):546-50. doi: 10.1016/j.amjsurg.2015.12.001. Epub 2015 Dec 22.

PMID:
26778767
15.

Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center.

Teo MC, Ching Tan GH, Lim C, Chia CS, Tham CK, Soo KC.

Asian J Surg. 2015 Apr;38(2):65-73. doi: 10.1016/j.asjsur.2014.05.001. Epub 2014 Jul 22.

16.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in a liver graft recipient: a case report.

Horvath P, Königsrainer I, Nadalin S, Beckert S, Löffler M, Königsrainer A.

Ann Transplant. 2013 Apr 22;18:182-6. doi: 10.12659/AOT.883893.

PMID:
23792519
17.

Ovarian preservation with subcutaneous transposition in the setting of cytoreductive surgery.

Tan WJ, Jung J, Chia CS, Teo MC, Toh HC, Soo KC.

Int J Surg Case Rep. 2013;4(3):305-7. doi: 10.1016/j.ijscr.2012.12.015. Epub 2013 Jan 17.

18.

Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.

McQuellon RP, Loggie BW, Lehman AB, Russell GB, Fleming RA, Shen P, Levine EA.

Ann Surg Oncol. 2003 Mar;10(2):155-62.

PMID:
12620911
19.

Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

Königsrainer I.

World J Gastroenterol. 2011 Oct 7;17(37):4153-6. doi: 10.3748/wjg.v17.i37.4153.

20.

Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.

Järvinen P, Ristimäki A, Kantonen J, Lepistö A.

Scand J Surg. 2013;102(3):145-51. doi: 10.1177/1457496913490463.

PMID:
23963027

Supplemental Content

Support Center